speb/financial-data huggingface dataset:
BIOA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -21563000.00
BIOA income_statement (quarterly, 2025-06-30) — EBIT: -21362000.00
BIOA income_statement (quarterly, 2025-06-30) — EBITDA: -21304000.00
BIOA cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -46000.00
BIOA cash_flow (quarterly, 2025-06-30) — End Cash Position: 220330000.00
BIOA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1500000.00
BIOA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -20128000.00
BIOA cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 11000.00
BIOA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -11000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 212000.00
BIOA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 7339000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4468000.00
BIOA income_statement (quarterly, 2025-06-30) — Interest Expense: 201000.00
BIOA income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 201000.00
BIOA income_statement (quarterly, 2025-06-30) — Interest Income: 3420000.00
BIOA income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 3420000.00
BIOA cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 176000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 300377000.00
BIOA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -15641000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 16108000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 16208000.00
BIOA cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
BIOA balance_sheet (quarterly, 2025-06-30) — Leases: 161000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2520000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2520000.00
BIOA cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1500000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 238000.00
BIOA income_statement (quarterly, 2025-06-30) — Net Income: -21563000.00
BIOA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -21563000.00
BIOA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -21563000.00
BIOA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -21563000.00
BIOA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -21563000.00
BIOA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -21563000.00
BIOA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -21563000.00
BIOA income_statement (quarterly, 2025-06-30) — Net Interest Income: 3219000.00
BIOA cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -15482000.00
BIOA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1500000.00
BIOA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1500000.00
BIOA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 3219000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Net PPE: 4006000.00
BIOA cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -159000.00
BIOA cash_flow (quarterly, 2025-06-30) — Net Preferred Stock Issuance: 0.00
BIOA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 294781000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1902000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 1902000.00
BIOA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -21293000.00
BIOA income_statement (quarterly, 2025-06-30) — Normalized Income: -21552000.00
BIOA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -19969000.00
BIOA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 11000.00
BIOA income_statement (quarterly, 2025-06-30) — Operating Income: -24771000.00
BIOA income_statement (quarterly, 2025-06-30) — Operating Revenue: 2412000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 35850037.00
BIOA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3799000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 5596000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 911000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 212000.00
BIOA income_statement (quarterly, 2025-06-30) — Other Gand A: 7339000.00
BIOA income_statement (quarterly, 2025-06-30) — Other Income Expense: -11000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Other Investments: 100000.00
BIOA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 83000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 237000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Other Properties: 4017000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 76965000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Payables: 1329000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 8002000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
BIOA cash_flow (quarterly, 2025-06-30) — Preferred Stock Issuance: 0.00
BIOA income_statement (quarterly, 2025-06-30) — Pretax Income: -21563000.00
BIOA cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
BIOA balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
BIOA cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -23982000.00
BIOA cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -159000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Receivables: 603000.00
BIOA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 58000.00
BIOA cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1500000.00
BIOA income_statement (quarterly, 2025-06-30) — Research And Development: 19844000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -287302000.00
BIOA cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 8500000.00
BIOA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 7339000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Share Issued: 35850037.00
BIOA income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
BIOA cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3229000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 294781000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 294781000.00
BIOA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BIOA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
BIOA balance_sheet (quarterly, 2025-06-30) — Total Assets: 322148000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 294781000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Total Debt: 8746000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 294781000.00
BIOA income_statement (quarterly, 2025-06-30) — Total Expenses: 27183000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 27367000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 20451000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 4530000.00
BIOA income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -24771000.00
BIOA income_statement (quarterly, 2025-06-30) — Total Unusual Items: -11000.00
BIOA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -11000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Working Capital: 278860000.00
BIOA income_statement (quarterly, 2025-09-30) — +Operating Expense: 25194000.00
BIOA income_statement (quarterly, 2025-09-30) — +Total Revenue: 2054000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5018000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 515000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -413000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 584662000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 10078000.00
BIOA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 35850037.00
BIOA income_statement (quarterly, 2025-09-30) — Basic EPS: -0.56
BIOA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 220330000.00
BIOA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -22000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3007000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
BIOA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 215573000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 285778000.00
BIOA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1544000.00
BIOA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 12841000.00
BIOA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -16044000.00
BIOA cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 3645000.00
BIOA cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -542000.00
BIOA cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 10000.00
BIOA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1538000.00
BIOA cash_flow (quarterly, 2025-09-30) — Change In Payable: 3645000.00
BIOA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 3103000.00
BIOA cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -436000.00
BIOA cash_flow (quarterly, 2025-09-30) — Change In Receivables: 88000.00
BIOA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1227000.00
BIOA cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 88000.00
BIOA cash_flow (quarterly, 2025-09-30) — Changes In Cash: -4747000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
BIOA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 277464000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 19000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 6373000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Current Assets: 290828000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 580000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Current Debt: 4126000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4706000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 7506000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 7506000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 24493000.00
BIOA cash_flow (quarterly, 2025-09-30) — Depreciation: 49000.00
BIOA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 49000.00
BIOA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 49000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 150000.00
BIOA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 35850037.00
BIOA income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.56
BIOA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -20171000.00
BIOA income_statement (quarterly, 2025-09-30) — EBIT: -20022000.00
BIOA income_statement (quarterly, 2025-09-30) — EBITDA: -19973000.00
BIOA cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -10000.00
BIOA cash_flow (quarterly, 2025-09-30) — End Cash Position: 215573000.00
BIOA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1544000.00
BIOA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -16066000.00
BIOA cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 42000.00
BIOA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -42000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 275000.00
BIOA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 6681000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4270000.00
BIOA income_statement (quarterly, 2025-09-30) — Interest Expense: 149000.00
BIOA income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 149000.00
BIOA income_statement (quarterly, 2025-09-30) — Interest Income: 3160000.00
BIOA income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 3160000.00
BIOA cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 133000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 281590000.00
BIOA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 12841000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 10078000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 10178000.00
BIOA cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
BIOA balance_sheet (quarterly, 2025-09-30) — Leases: 161000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2427000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2427000.00
BIOA cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1500000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 239000.00
BIOA income_statement (quarterly, 2025-09-30) — Net Income: -20171000.00
BIOA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -20171000.00
BIOA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -20171000.00
BIOA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -20171000.00
BIOA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -20171000.00
BIOA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -20171000.00
BIOA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -20171000.00
BIOA income_statement (quarterly, 2025-09-30) — Net Interest Income: 3011000.00
BIOA cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 12863000.00
BIOA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1500000.00
BIOA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1500000.00
BIOA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 3011000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Net PPE: 3857000.00
BIOA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -22000.00
BIOA cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
BIOA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 277464000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 556000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 556000.00
BIOA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -19931000.00
BIOA income_statement (quarterly, 2025-09-30) — Normalized Income: -20129000.00
BIOA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -16044000.00
BIOA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 42000.00
BIOA income_statement (quarterly, 2025-09-30) — Operating Income: -23140000.00
BIOA income_statement (quarterly, 2025-09-30) — Operating Revenue: 2054000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 35850037.00
BIOA balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 4535000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 4126000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 890000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 275000.00
BIOA income_statement (quarterly, 2025-09-30) — Other Gand A: 6681000.00
BIOA income_statement (quarterly, 2025-09-30) — Other Income Expense: -42000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Other Investments: 100000.00
BIOA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 18000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 227000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Other Properties: 3851000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 70205000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Payables: 5018000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 11391000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BIOA cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 0.00
BIOA income_statement (quarterly, 2025-09-30) — Pretax Income: -20171000.00
BIOA cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
BIOA balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
BIOA cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -12887000.00
BIOA cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -22000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Receivables: 515000.00
BIOA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 49000.00
BIOA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1500000.00
BIOA income_statement (quarterly, 2025-09-30) — Research And Development: 18513000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -307473000.00
BIOA cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 25750000.00
BIOA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 6681000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Share Issued: 35850037.00
BIOA income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
BIOA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2791000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 277464000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 277464000.00
BIOA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BIOA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
BIOA balance_sheet (quarterly, 2025-09-30) — Total Assets: 305090000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 277464000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Total Debt: 7133000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 277464000.00
BIOA income_statement (quarterly, 2025-09-30) — Total Expenses: 25194000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 27626000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 14262000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3133000.00
BIOA income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -23140000.00
BIOA income_statement (quarterly, 2025-09-30) — Total Unusual Items: -42000.00
BIOA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -42000.00
BIOA balance_sheet (quarterly, 2025-09-30) — Working Capital: 266335000.00
BIOA income_statement (annual, 2025-12-31) — +Operating Expense: 101775000.00
BIOA income_statement (quarterly, 2025-12-31) — +Operating Expense: 31501000.00
BIOA income_statement (annual, 2025-12-31) — +Total Revenue: 8995000.00
BIOA income_statement (quarterly, 2025-12-31) — +Total Revenue: 3078000.00
BIOA balance_sheet (annual, 2025-12-31) — Accounts Payable: 2674000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2674000.00
BIOA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 769000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 769000.00
BIOA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -482000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -482000.00
BIOA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 605189000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 605189000.00
BIOA balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 4032000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 4032000.00
BIOA income_statement (annual, 2025-12-31) — Basic Average Shares: 35932914.00
BIOA income_statement (annual, 2025-12-31) — Basic EPS: -2.24
BIOA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 354349000.00
BIOA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 215573000.00
BIOA cash_flow (annual, 2025-12-31) — Capital Expenditure: -719000.00
BIOA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -112000.00
BIOA balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2912000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2912000.00
BIOA balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
BIOA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
BIOA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 188888000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 188888000.00
BIOA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 281098000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 281098000.00
BIOA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 11469000.00
BIOA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 16013000.00
BIOA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -95216000.00
BIOA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -14428000.00
BIOA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -81627000.00
BIOA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -28251000.00
BIOA cash_flow (annual, 2025-12-31) — Change In Account Payable: 788000.00
BIOA cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2307000.00
BIOA cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -3412000.00
BIOA cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 1354000.00
BIOA cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 24000.00
BIOA cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 11000.00
BIOA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -6746000.00
BIOA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -2308000.00
BIOA cash_flow (annual, 2025-12-31) — Change In Payable: 788000.00
BIOA cash_flow (quarterly, 2025-12-31) — Change In Payable: -2307000.00
BIOA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -2624000.00
BIOA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -953000.00
BIOA cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -1713000.00
BIOA cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -232000.00
BIOA cash_flow (annual, 2025-12-31) — Change In Receivables: -769000.00
BIOA cash_flow (quarterly, 2025-12-31) — Change In Receivables: -254000.00
BIOA cash_flow (annual, 2025-12-31) — Change In Working Capital: -11828000.00
BIOA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3736000.00
BIOA cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -769000.00
BIOA cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -254000.00
BIOA cash_flow (annual, 2025-12-31) — Changes In Cash: -165374000.00
BIOA cash_flow (quarterly, 2025-12-31) — Changes In Cash: -26666000.00
BIOA balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
BIOA balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
BIOA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 272051000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 272051000.00
BIOA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 17155000.00
BIOA cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 17155000.00
BIOA balance_sheet (annual, 2025-12-31) — Construction In Progress: 22000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 22000.00
BIOA balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 7955000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 7955000.00
BIOA balance_sheet (annual, 2025-12-31) — Current Assets: 286793000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Current Assets: 286793000.00
BIOA balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 582000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 582000.00
BIOA balance_sheet (annual, 2025-12-31) — Current Debt: 2648000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Current Debt: 2648000.00
BIOA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 3230000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 3230000.00
BIOA balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 5754000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 5754000.00
BIOA balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 5754000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 5754000.00
BIOA balance_sheet (annual, 2025-12-31) — Current Liabilities: 20138000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 20138000.00
BIOA cash_flow (annual, 2025-12-31) — Depreciation: 213000.00
BIOA cash_flow (quarterly, 2025-12-31) — Depreciation: 69000.00
BIOA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 213000.00
BIOA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 69000.00
BIOA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 213000.00
BIOA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 69000.00
BIOA balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 370000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 370000.00
BIOA income_statement (annual, 2025-12-31) — Diluted Average Shares: 35932914.00
BIOA income_statement (annual, 2025-12-31) — Diluted EPS: -2.24
BIOA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -80605000.00
BIOA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -25943000.00
BIOA income_statement (annual, 2025-12-31) — EBIT: -79908000.00
BIOA income_statement (quarterly, 2025-12-31) — EBIT: -25851000.00
BIOA income_statement (annual, 2025-12-31) — EBITDA: -79695000.00
BIOA income_statement (quarterly, 2025-12-31) — EBITDA: -25782000.00
BIOA cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -87000.00
BIOA cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -19000.00
BIOA cash_flow (annual, 2025-12-31) — End Cash Position: 188888000.00
BIOA cash_flow (quarterly, 2025-12-31) — End Cash Position: 188888000.00
BIOA cash_flow (annual, 2025-12-31) — Financing Cash Flow: 11469000.00
BIOA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 16013000.00
BIOA cash_flow (annual, 2025-12-31) — Free Cash Flow: -82346000.00
BIOA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -28363000.00
BIOA cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 214000.00
BIOA cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 220000.00
BIOA cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 23000.00
BIOA income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -214000.00
BIOA income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -220000.00
BIOA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 278000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 278000.00
BIOA income_statement (annual, 2025-12-31) — General And Administrative Expense: 27809000.00
BIOA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 7001000.00
BIOA balance_sheet (annual, 2025-12-31) — Gross PPE: 4230000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4230000.00
BIOA income_statement (annual, 2025-12-31) — Interest Expense: 697000.00
BIOA income_statement (quarterly, 2025-12-31) — Interest Expense: 92000.00
BIOA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 697000.00
BIOA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 92000.00
BIOA income_statement (annual, 2025-12-31) — Interest Income: 13086000.00
BIOA income_statement (quarterly, 2025-12-31) — Interest Income: 2792000.00
BIOA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 13086000.00
BIOA income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2792000.00
BIOA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 611000.00
BIOA cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 85000.00
BIOA balance_sheet (annual, 2025-12-31) — Invested Capital: 274699000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 274699000.00
BIOA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -95216000.00
BIOA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -14428000.00
BIOA balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 4032000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 4032000.00
BIOA balance_sheet (annual, 2025-12-31) — Investments And Advances: 4132000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 4132000.00
BIOA cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 17155000.00
BIOA cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 17155000.00
BIOA balance_sheet (annual, 2025-12-31) — Leases: 161000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Leases: 161000.00
BIOA balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2330000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2330000.00
BIOA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2330000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2330000.00
BIOA cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -6000000.00
BIOA cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1500000.00
BIOA balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 239000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 239000.00
BIOA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 17155000.00
BIOA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 17155000.00
BIOA income_statement (annual, 2025-12-31) — Net Income: -80605000.00
BIOA income_statement (quarterly, 2025-12-31) — Net Income: -25943000.00
BIOA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -80605000.00
BIOA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -25943000.00
BIOA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -80605000.00
BIOA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -25943000.00
BIOA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -80605000.00
BIOA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -25943000.00
BIOA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -80605000.00
BIOA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -25943000.00
BIOA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -80605000.00
BIOA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -25943000.00
BIOA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -80605000.00
BIOA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -25943000.00
BIOA income_statement (annual, 2025-12-31) — Net Interest Income: 12389000.00
BIOA income_statement (quarterly, 2025-12-31) — Net Interest Income: 2700000.00
BIOA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -94497000.00
BIOA cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -14316000.00
BIOA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -6000000.00
BIOA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1500000.00
BIOA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -6000000.00
BIOA cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -1500000.00
BIOA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 12389000.00
BIOA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 2700000.00
BIOA cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -400000.00
BIOA cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -356000.00
BIOA balance_sheet (annual, 2025-12-31) — Net PPE: 3748000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Net PPE: 3748000.00
BIOA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -719000.00
BIOA cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -112000.00
BIOA cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
BIOA cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
BIOA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 272051000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 272051000.00
BIOA balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 0.00
BIOA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 0.00
BIOA balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 0.00
BIOA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 0.00
BIOA income_statement (annual, 2025-12-31) — Normalized EBITDA: -79481000.00
BIOA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -25562000.00
BIOA income_statement (annual, 2025-12-31) — Normalized Income: -80391000.00
BIOA income_statement (quarterly, 2025-12-31) — Normalized Income: -25723000.00
BIOA cash_flow (annual, 2025-12-31) — Operating Cash Flow: -81627000.00
BIOA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -28251000.00
BIOA cash_flow (annual, 2025-12-31) — Operating Gains Losses: 237000.00
BIOA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 243000.00
BIOA income_statement (annual, 2025-12-31) — Operating Income: -92780000.00
BIOA income_statement (quarterly, 2025-12-31) — Operating Income: -28423000.00
BIOA income_statement (annual, 2025-12-31) — Operating Revenue: 8995000.00
BIOA income_statement (quarterly, 2025-12-31) — Operating Revenue: 3078000.00
BIOA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 37386908.00
BIOA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 37386908.00
BIOA balance_sheet (annual, 2025-12-31) — Other Current Assets: 4926000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 4926000.00
BIOA balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 2648000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 2648000.00
BIOA balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 525000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 525000.00
BIOA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 278000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 278000.00
BIOA income_statement (annual, 2025-12-31) — Other Gand A: 27809000.00
BIOA income_statement (quarterly, 2025-12-31) — Other Gand A: 7001000.00
BIOA income_statement (annual, 2025-12-31) — Other Income Expense: -214000.00
BIOA income_statement (quarterly, 2025-12-31) — Other Income Expense: -220000.00
BIOA balance_sheet (annual, 2025-12-31) — Other Investments: 100000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Other Investments: 100000.00
BIOA cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1335000.00
BIOA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -1606000.00
BIOA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 216000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 216000.00
BIOA balance_sheet (annual, 2025-12-31) — Other Properties: 3808000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Other Properties: 3808000.00
BIOA balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 92210000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 92210000.00
BIOA balance_sheet (annual, 2025-12-31) — Payables: 2674000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Payables: 2674000.00
BIOA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 10629000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 10629000.00
BIOA balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
BIOA balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
BIOA cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
BIOA cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
BIOA income_statement (annual, 2025-12-31) — Pretax Income: -80605000.00
BIOA income_statement (quarterly, 2025-12-31) — Pretax Income: -25943000.00
BIOA cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 714000.00
BIOA cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 714000.00
BIOA balance_sheet (annual, 2025-12-31) — Properties: 0.00
BIOA balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BIOA cash_flow (annual, 2025-12-31) — Purchase Of Investment: -154747000.00
BIOA cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -40316000.00
BIOA cash_flow (annual, 2025-12-31) — Purchase Of PPE: -719000.00
BIOA cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -112000.00
BIOA balance_sheet (annual, 2025-12-31) — Receivables: 769000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Receivables: 769000.00
BIOA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 213000.00
BIOA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 69000.00
BIOA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -6000000.00
BIOA cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1500000.00
BIOA income_statement (annual, 2025-12-31) — Research And Development: 73966000.00
BIOA income_statement (quarterly, 2025-12-31) — Research And Development: 24500000.00
BIOA balance_sheet (annual, 2025-12-31) — Retained Earnings: -333416000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -333416000.00
BIOA cash_flow (annual, 2025-12-31) — Sale Of Investment: 60250000.00
BIOA cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 26000000.00
BIOA income_statement (annual, 2025-12-31) — Selling General And Administration: 27809000.00
BIOA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 7001000.00
BIOA balance_sheet (annual, 2025-12-31) — Share Issued: 37386908.00
BIOA balance_sheet (quarterly, 2025-12-31) — Share Issued: 37386908.00
BIOA income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
BIOA income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
BIOA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 11691000.00
BIOA cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2722000.00
BIOA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 272051000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 272051000.00
BIOA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 272051000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 272051000.00
BIOA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BIOA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BIOA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
BIOA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
BIOA balance_sheet (annual, 2025-12-31) — Total Assets: 294889000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Total Assets: 294889000.00
BIOA balance_sheet (annual, 2025-12-31) — Total Capitalization: 272051000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 272051000.00
BIOA balance_sheet (annual, 2025-12-31) — Total Debt: 5560000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Total Debt: 5560000.00
BIOA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 272051000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 272051000.00
BIOA income_statement (annual, 2025-12-31) — Total Expenses: 101775000.00
BIOA income_statement (quarterly, 2025-12-31) — Total Expenses: 31501000.00
BIOA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 22838000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 22838000.00
BIOA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 8096000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 8096000.00
BIOA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2700000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2700000.00
BIOA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -92780000.00
BIOA income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -28423000.00
BIOA income_statement (annual, 2025-12-31) — Total Unusual Items: -214000.00
BIOA income_statement (quarterly, 2025-12-31) — Total Unusual Items: -220000.00
BIOA income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -214000.00
BIOA income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -220000.00
BIOA balance_sheet (annual, 2025-12-31) — Working Capital: 266655000.00
BIOA balance_sheet (quarterly, 2025-12-31) — Working Capital: 266655000.00
BIOA income_statement (quarterly, 2026-03-31) — +Operating Expense: 28147000.00
BIOA income_statement (quarterly, 2026-03-31) — +Total Revenue: 2772000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3066000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 709000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -543000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 734717000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1680000.00
BIOA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 42480488.00
BIOA income_statement (quarterly, 2026-03-31) — Basic EPS: -0.52
BIOA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 188888000.00
BIOA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -26000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2875000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
BIOA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 241777000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 383194000.00
BIOA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 123715000.00
BIOA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -46753000.00
BIOA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -24046000.00
BIOA cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 326000.00
BIOA cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -3843000.00
BIOA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 1000.00
BIOA cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 437000.00
BIOA cash_flow (quarterly, 2026-03-31) — Change In Payable: 326000.00
BIOA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -3517000.00
BIOA cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -2975000.00
BIOA cash_flow (quarterly, 2026-03-31) — Change In Receivables: 60000.00
BIOA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -5994000.00
BIOA cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 60000.00
BIOA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 52916000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
BIOA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 379121000.00
BIOA cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 124315000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 149000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 4051000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Current Assets: 391860000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 646000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Current Debt: 1159000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1805000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 6191000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 6191000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 15827000.00
BIOA cash_flow (quarterly, 2026-03-31) — Depreciation: 63000.00
BIOA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 63000.00
BIOA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 63000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 477000.00
BIOA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 42480488.00
BIOA income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.52
BIOA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -22253000.00
BIOA income_statement (quarterly, 2026-03-31) — EBIT: -22214000.00
BIOA income_statement (quarterly, 2026-03-31) — EBITDA: -22151000.00
BIOA cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -27000.00
BIOA cash_flow (quarterly, 2026-03-31) — End Cash Position: 241777000.00
BIOA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 123715000.00
BIOA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -24072000.00
BIOA cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 107000.00
BIOA income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -107000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 73000.00
BIOA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 7737000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4342000.00
BIOA income_statement (quarterly, 2026-03-31) — Interest Expense: 39000.00
BIOA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 39000.00
BIOA income_statement (quarterly, 2026-03-31) — Interest Income: 3268000.00
BIOA income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3268000.00
BIOA cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 41000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 380280000.00
BIOA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -46753000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1680000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 1780000.00
BIOA cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 124315000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Leases: 161000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2229000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2229000.00
BIOA cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1500000.00
BIOA balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 236000.00